Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · USD

$8.50

+0.24 (+2.9%)· Recorded snapshot

Market cap	2.2B
Revenue (ttm)	208.8M
Net income (ttm)	-77.4M
EPS (ttm)	-$0.53
Shares out	259.7M
Volume	2,318,175
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 208.8M
Net income (ttm): -77.4M
EPS (ttm): -$0.53
Market cap: 2.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-33

P25 -113.8P50 -46.5P75 -0.9

ROIC-13.4

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All MRVI indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001823239
Company name	Maravai LifeSciences Holdings, Inc.
Country	United States
Country code	US
CUSIP number	56600D107
Earnings date	2026-11-04
Earnings time	amc
Employees	415
Employees change	-145
Employees growth	-25.89%
Enterprise value	$2.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-11-20
Is primary listing	Yes
Is SPAC	No
ISIN number	US56600D1072
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$8.50
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MRVI
U.S. state	California
Website	https://www.maravai.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-6.23%
EV/Sales	11.18x
FCF / EV yield	-1.54%
FCF yield	-1.64%
Forward EV/Sales	10.95x
Forward P/S	10.25x
P/B ratio	6.01x
P/S ratio	10.47x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-32.82%
EBITDA margin	-9.46%
Gross margin	35.71%
Operating margin	-32.82%
Pretax margin	-65.38%
Profit margin	-37.07%
Profit per employee	$-186,472
Revenue per employee	$503,072
ROA	-5.71%
ROA (5Y)	4.97%
ROCE	-12.12%
ROE	-33.05%
ROE (5Y)	19.76%
ROIC	-13.41%
ROIC (5Y)	25.8%
SBC / revenue	14.34%
Tax / revenue	-0.2%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	1
FCF growth (QoQ)	-14.33%
Gross profit growth	11.07%
Gross profit growth (Q)	165.83%
Gross profit growth 3Y	-41.67%
Gross profit growth 5Y	-29.88%
Net income growth quarters	2
Net income growth years	1
OCF growth (QoQ)	-53.93%
Revenue growth	-5.03%
Revenue growth (Q)	8.53%
Revenue growth (QoQ)	-21.86%
Revenue growth 3Y	-27.33%
Revenue growth 5Y	-17.68%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-10.6M
Depreciation and amortization	$48.8M
EBIT	$-68.5M
EBITDA	$-19.7M
EPS	$-0.53
FCF per share	$-0.14
Financing cash flow	$-164.3M
Free cash flow	$-35.8M
Free cash flow minus SBC	$-65.8M
Gross profit	$74.5M
Income taxes	$-408,000
Investing cash flow	$-9.8M
Net borrowing	$-147M
Net cash flow	$-199.3M
Net income	$-77.4M
Operating cash flow minus SBC	$-55.2M
Operating income	$-68.5M
Revenue	$208.8M
Stock-based compensation	$29.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.39
Book value per share	$1.37
Debt / EBITDA	49.18
Debt / equity	0.61
Goodwill	$129.4M
Interest coverage	-2.86
Long-term assets	$448.1M
Long-term liabilities	$209.7M
Net cash (debt)	$-148M
Net cash / market cap	-6.77%
Net debt / equity	0.42
Piotroski F-Score	4
Property, plant and equipment	$142.4M
Shareholders' equity	$355.6M
Tangible book value	$-63.2M
Tangible book value per share	$-0.42
Total assets	$603.7M
Total cash	$70.1M
Total debt	$218.1M
Total liabilities	$248.2M
WACC	7.37%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.28
Current assets	$155.7M
Current liabilities	$38.4M
Current ratio	4.05
Inventory turnover	3.05
Net working capital	$57.8M
Quick ratio	2.63
Working capital	$117.2M
Working capital turnover	1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.29%
Dividend yield	0%
Shareholder yield	-2.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$5.80
1D price change	2.91%
1M price change	9.87%
1M total return	9.87%
1W price change	15.97%
1W total return	15.97%
1Y price change	150%
1Y return CAGR	150.16%
1Y total return	150%
20-day SMA	$7.41
200-day SMA	$5.19
3M price change	24.81%
3M total return	24.81%
3Y price change	34.24%
3Y return CAGR	10.31%
3Y total return	34.24%
50-day SMA	$7.48
50-day SMA vs 200-day SMA	50over200
52-week high	$9.42
52-week high date	2026-08-26
52-week low	$2.55
52-week low date	2025-11-07
5Y price change	-80.08%
5Y return CAGR	-27.58%
5Y total return	-80.08%
6M price change	126.9%
6M total return	126.9%
All-time high	$63.55
All-time high date	2021-08-23
All-time low	$1.67
All-time low date	2025-04-17
Average true range (ATR)	$0.48
Average volume	2.6M
Beta (1Y)	0.29
Beta (2Y)	1.16
Beta (5Y)	0.54
Change from 52-week high	-9.77%
Change from 52-week low	233.99%
Change from all-time high	-86.86%
Change from all-time low	401.5%
Change from open	3.41%
Day's gap	-0.48%
Dollar volume	$19.7M
High price	$8.52
Low price	$8.16
Monthly RSI	60
Open price	$8.22
Position in 52-week range	94.44%
Premarket change	-0.61%
Premarket close	$8.26
Premarket price	$8.21
Premarket volume	5.5K
Previous close	$8.26
Price vs 150-day SMA	43.94%
Price vs 20-day SMA	12.69%
Price vs 200-day SMA	60.79%
Price vs 50-day SMA	11.65%
Relative volume	0.89
Return from IPO open	-73.65%
Return from IPO price	-68.81%
RSI	61.97
Sharpe ratio	1.6
Sharpe ratio (3Y)	0.45
Sharpe ratio (5Y)	-0.1
Sortino ratio	3.02
Sortino ratio (3Y)	0.8
Sortino ratio (5Y)	-0.07
Volume	2.3M
Weekly RSI	62.96
YTD price change	156.92%
YTD total return	156.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	106.4M
Float percentage	40.98%
Shares change (QoQ)	1.07%
Shares change (YoY)	2.29%
Shares held by insiders	3.55%
Shares held by institutions	75.2%
Shares outstanding	259.7M
Short % of float	12.99%
Short % of shares	5.32%
Short ratio	5.2 days

Deeper analysis on MRVI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MRVI report

Is a complete MRVI research report available?

No complete published report is available for Maravai LifeSciences Holdings, Inc. (MRVI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Maravai LifeSciences Holdings, Inc. (MRVI)

Price

Financial snapshot

Fair-value bridge

Latest news · MRVI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MRVI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MRVI

Frequently asked questions